Milan, Italy

Fulvio Uberti

This inventor holds 1 USPTO granted patent. Top assignee: Dibra S.p.a.. Active years: 1999.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Fulvio Uberti: Innovator in Tetraazamacrocycle Preparation

Introduction

Fulvio Uberti is a notable inventor based in Milan, Italy. He has made significant contributions to the field of chemistry, particularly in the preparation of complex compounds. His innovative work has led to the development of a unique process that enhances the synthesis of tetraazamacrocycles.

Latest Patents

Fulvio Uberti holds a patent for a "Process for the preparation of tetraazamacrocycles." This patent outlines a method for creating compounds of specific formulas, detailing the steps involved in the synthesis process. His patent is a testament to his expertise and dedication to advancing chemical processes.

Career Highlights

Uberti is associated with Dibra S.p.a., where he applies his knowledge and skills in a professional setting. His work at the company has allowed him to explore innovative solutions in the field of chemistry. With a focus on research and development, he continues to push the boundaries of what is possible in his area of expertise.

Collaborations

Throughout his career, Fulvio has collaborated with talented individuals such as Marcella Murru and Emanuela Panetta. These partnerships have fostered a creative environment that encourages the exchange of ideas and the pursuit of groundbreaking research.

Conclusion

Fulvio Uberti's contributions to the field of chemistry, particularly through his patent on tetraazamacrocycles, highlight his role as an innovator. His work at Dibra S.p.a. and collaborations with esteemed colleagues further emphasize his commitment to advancing scientific knowledge.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…